AstraZeneca PLC (AZN) Patient Assistance Programs Provided More Than Half A Million Patients With Free Medicine In 2013
2/20/2014 8:53:48 AM
WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca (NYSE:AZN) announced today that, in 2013, it provided nearly $975 million in savings to more than 567,000 patients in the United States through its patient assistance programs. These programs include AZ&Me and the MedImmune Assistance Program.
Help employers find you! Check out all the jobs and post your resume.
comments powered by